Key Insights

Highlights

Treatment Research

2 treatments under study, led by Tfv Ivr

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 2 (1)

Trial Status

Unknown1

Clinical Trials (1)

Showing 1 of 1 trials
NCT03762382Phase 2Unknown

Tenofovir/Levonorgestrel Intravaginal Ring and Tenofovir Intravaginal Ring

Showing all 1 trials

Research Network

Common Treatments

  • Tfv Ivr1
  • Tfvlng Ivr1

Active Sponsors

  • CONRAD1
  • Kenya Medical Research Institute1
  • Centers for Disease Control and Prevention1
  • University of Washington1

Top Investigators

Related Conditions

  • Hiv1
  • Contraception1
  • Prevention1

Activity Timeline